Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Other companies in Inhibrx Biosciences’s space includes: Upstream Bio (NASDAQ:UPB), CureVac (NASDAQ:CVAC), Day One Biopharmaceutical (NASDAQ:DAWN), Pharming (NASDAQ:PHAR) and Xencor (NASDAQ:XNCR).
Inhibrx Biosciences has a consensus price target of $40.50.
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $72.1 last updated November 12, 2025 at 7:21 PM EST.
There are no upcoming dividends for Inhibrx Biosciences.
Inhibrx Biosciences’s Q3 earnings are confirmed for Tuesday, November 25, 2025.
There is no upcoming split for Inhibrx Biosciences.
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.